104 related articles for article (PubMed ID: 9773750)
1. Chorea in hyperglycemia.
Piccolo I; Sterzi R; Thiella G
Diabetes Care; 1998 Oct; 21(10):1777. PubMed ID: 9773750
[No Abstract] [Full Text] [Related]
2. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
Medina Santillán R; Reyes-García G; Mateos-García E
Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
[No Abstract] [Full Text] [Related]
3. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
4. Glyburide/metformin (Glucovance) for type 2 diabetes.
Med Lett Drugs Ther; 2000 Nov; 42(1092):105-6. PubMed ID: 11077467
[No Abstract] [Full Text] [Related]
5. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
Medina Santillán R; Reyes-García G; Mateos-García E
Proc West Pharmacol Soc; 2002; 45():137-8. PubMed ID: 12434558
[No Abstract] [Full Text] [Related]
6. Management of diabetes in cardiovascular patients: diabetic heart disease.
Peter R; Cox A; Evans M
Heart; 2008 Mar; 94(3):369-75. PubMed ID: 18276822
[No Abstract] [Full Text] [Related]
7. Teaching Video NeuroImages: hemichorea-hemiballismus secondary to nonketotic hyperglycemia.
Vale TC; Freitas Dda S; Maciel RO; Miranda EC; Cardoso F
Neurology; 2013 Apr; 80(16):e178. PubMed ID: 23589647
[No Abstract] [Full Text] [Related]
8. Choosing first-line therapy for management of type 2 diabetes.
Graber MA; Darby-Stewart A; Dachs R
Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
[No Abstract] [Full Text] [Related]
9. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
André P
Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
[No Abstract] [Full Text] [Related]
10. Patient characteristics not described.
Lofsky S
CMAJ; 2006 Jun; 174(13):1874. PubMed ID: 16785468
[No Abstract] [Full Text] [Related]
11. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
[TBL] [Abstract][Full Text] [Related]
12. [Metformin in the UKPDS study. Metabolic and vascular results].
Basin C; Isnard F
Journ Annu Diabetol Hotel Dieu; 1999; ():243-61. PubMed ID: 10732421
[No Abstract] [Full Text] [Related]
13. Role of oral anti-diabetic agents in modifying cardiovascular risk factors.
Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR
Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468
[TBL] [Abstract][Full Text] [Related]
14. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
15. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
Woo V;
Diabetes Care; 2009 Mar; 32(3):e34; author reply e37-8. PubMed ID: 19246585
[No Abstract] [Full Text] [Related]
16. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
Lebovitz HE
Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
[TBL] [Abstract][Full Text] [Related]
17. [Coma in type 2 diabete mellitus on metformin treatment].
Renard C; Tellal S; Fevre G; Ragot C; Vest P; Foissaud V; Renaudeau C
Ann Biol Clin (Paris); 2003; 61(1):84-7. PubMed ID: 12604391
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
Niskanen L; Uusitupa M; Laakso M
Duodecim; 1999; 115(10):1122-4. PubMed ID: 11877851
[No Abstract] [Full Text] [Related]
19. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.
Kanna B; Abreu-Pacheco H
Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531
[No Abstract] [Full Text] [Related]
20. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
Kahn SE; Zinman B; Lachin JM; Haffner SM; Herman WH; Holman RR; Kravitz BG; Yu D; Heise MA; Aftring RP; Viberti G;
Diabetes Care; 2008 May; 31(5):845-51. PubMed ID: 18223031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
